Heart BMJ

NOVEMBER 27, 2023

There were great advances in the treatment of heart failure (HF) over the past decades, characterised by the inclusion of ARNI and SGLT2 inhibitors in the latest guidelines. 1 The increasing repertoire of treatments makes it even more important to select those patients who will benefit the most from these therapies.

Cardiomyopathy 40

Cardiomyopathy Heart Transplant Transplant Heart Failure 40

The American Journal of Cardiology

DECEMBER 17, 2023

Publication date: Available online 16 December 2023 Source: The American Journal of Cardiology Author(s): Pierre Ambrosi, Alberto Riberi, Shahram Attarian, Karine Nguyen, Régis Guieu, Gilbert Habib

Heart Transplant 40

Heart Transplant Transplant Cardiomyopathy 40

European Journal of Heart Failure

FEBRUARY 25, 2025

Abstract Aims The CASTLE-HTx trial showed the benefit of atrial fibrillation (AF) ablation compared to medical therapy in decreasing mortality, need for left ventricular assist device implantation or heart transplantation (HTx) in patients with end-stage heart failure (HF).

Atrial Fibrillation 40

Atrial Fibrillation Ablation Heart Failure Arrhythmia 40

European Journal of Heart Failure

NOVEMBER 9, 2023

The primary composite endpoint included all-cause mortality, heart transplantation, or ventricular assist device implantation. The secondary endpoint was first heart failure admission. vs. 28.8%, p  < 0.001), more often had ischeemic cardiomyopathy (49.8% ml/min/1.73 m ml/min/1.73 m 76.5], p  < 0.001).

Outcomes 40

Outcomes Heart Failure Heart Transplant Transplant 40

European Journal of Heart Failure

APRIL 13, 2025

Aims The prognostic significance of detecting left ventricular (LV) systolic dysfunction during family screening programmes (FSPs) in relatives of probands affected by dilated (DCM) and non-dilated left ventricular (NDLVC) cardiomyopathies remain unclear. The primary outcome was all-cause death and heart transplantation.

Cardiomyopathy 40

Cardiomyopathy Heart Transplant Electrocardiogram Transplant 40

Circulation

JANUARY 9, 2025

Children with cardiomyopathy and adults with CHD did not experience the mortality benefits experienced by adults with cardiomyopathy and children with CHD.

Congenital Heart Disease 49

Congenital Heart Disease Pediatrics Cardiomyopathy Transplant 49

MIBHS

OCTOBER 31, 2024

Coronary Artery Disease (CAD) CAD, which involves the narrowing or blockage of coronary arteries due to plaque buildup, can reduce blood flow to the heart. This may result in ischemia (lack of oxygen to the heart muscle), causing parts of the heart to weaken and enlarge.

Blood Pressure 52

Blood Pressure Blood Clot Heart Valves Heart Rhythm 52

All About Cardiovascular System and Disorders

FEBRUARY 24, 2024

Arrhythmogenic Cardiomyopathy was better known as Arrhythmogenic Right Ventricular Dysplasia or ARVD and sometimes as Arrhythmogenic Right Ventricular Cardiomyopathy or ARVC earlier. A study published in JACC has compared the phenotypic expression and clinical outcomes in patients with arrhythmogenic cardiomyopathy [2].

Cardiomyopathy 52

Cardiomyopathy Chest Pain Heart Transplant Arrhythmia 52

Frontiers in Cardiovascular Medicine

NOVEMBER 19, 2024

BackgroundRestrictive cardiomyopathy (RCM) is a rare cardiomyopathy often characterized by normal or reduced ventricular chamber volume and bi-atrial enlargement, caused mainly by mutations in the myonodal gene.

Cardiomyopathy 45

Cardiomyopathy Heart Transplant Transplant Electrocardiogram 45

DAIC

APRIL 30, 2024

Heart attacks typically kill millions of cardiac muscle cells, leaving the heart in a weakened state. Since mammals cannot regenerate cardiac muscle cells on their own, heart transplants are currently the only clinically viable option for patients suffering (or likely to suffer) heart failure.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart Attack 105

Dr. Smith's ECG Blog

JUNE 2, 2023

Overall CMR findings are consistent with arrhythmogenic cardiomyopathy. Here is a 2017 review article on ARVD in the New England Journal There is a 2010 publication by the Task Force in Diagnosis of ARVD: Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.

Tachycardia 96

Tachycardia Cardiomyopathy Electrocardiogram Article 96

DAIC

FEBRUARY 22, 2024

Researchers Elizabeth Jordan and Ray Hershberger, MD discuss the results of genetic tests that indicate a risk for dilated cardiomyopathy. The inherited heart condition often goes undiagnosed until it advances to heart failure, which is why it’s important to identify those at risk and begin treatment early.

Heart Failure 104

Heart Failure Sudden Cardiac Death Heart Transplant Cardiomyopathy 104

Circulation: Genomic and Precision Medicine

SEPTEMBER 6, 2023

Background:Variants in theDMDgene, that encodes the cytoskeletal protein, dystrophin, cause a severe form of dilated cardiomyopathy (DCM) associated with high rates of heart failure, heart transplantation, and ventricular arrhythmias.

Cardiomyopathy 40

Cardiomyopathy Heart Transplant Transplant Heart Failure 40

European Journal of Heart Failure

NOVEMBER 11, 2024

Cardiovascular mortality, driven by sudden cardiac death, is the main reason for dying while waiting for heart transplantation (HTx). Methods CASTLE-VT is a randomized evaluation of prophylactic ablative treatment of arrhythmogenic ventricular scar in patients referred for HTx evaluation and diagnosed with ICM.

Heart Transplant 40

Heart Transplant Transplant Heart Failure Ablation 40

Circulation: Cardiovascular Imaging

DECEMBER 18, 2023

BACKGROUND:Imaging evaluation of arrhythmogenic right ventricular cardiomyopathy (ARVC) remains challenging. LV global longitudinal strain did not add diagnostic value but was prognostic for composite end points of death, heart transplantation, or ventricular arrhythmia (log-rankP=0.04).CONCLUSIONS:In

Cardiomyopathy 40

Cardiomyopathy Heart Transplant Cardiovascular Imaging Transplant 40

Frontiers in Cardiovascular Medicine

APRIL 8, 2025

Background and aimDilated cardiomyopathy (DCM) is the most common heart muscle disease presenting in childhood and is associated with an increased risk of heart failure related death. Studies were excluded if imaging characteristics were not described.ResultsThirteen studies (1,348 patients) met the inclusion criteria.

Risk Factors 52

Risk Factors Heart Failure Cardiomyopathy Heart Transplant 52

Journal of the American Heart Association

JANUARY 12, 2024

Journal of the American Heart Association, Ahead of Print. BackgroundPediatric dilated cardiomyopathy often leads to death or cardiac transplantation. The risk for death or cardiac transplantation up to 7 years later was lower when LVFS was improved at 1 year (hazard ratio [HR], 0.83;P=0.004) P&lt;0.001).ConclusionsProgressive

Cardiomyopathy 40

Cardiomyopathy Pediatrics Transplant Heart Transplant 40

Circulation: Heart Failure

FEBRUARY 1, 2024

Circulation: Heart Failure, Ahead of Print. BACKGROUND:In 2018, an algorithm-based allocation system for heart transplantation (HT) was implemented in France. The cumulative incidence of waitlist mortality estimated with competing risk analysis and incidence of transplantation were compared between diagnosis groups.

Heart Failure 40

Heart Failure Congenital Heart Disease Congenital Cardiomyopathy 40

DAIC

APRIL 6, 2024

This hierarchical composite approach for assessing efficacy allows diverse types of outcomes to be incorporated in ranked fashion into an overall “win ratio” reflecting the overall outcome of a drug or device.

Heart Failure 81

Heart Failure Quality of Life Outcomes Preserved Ejection Fraction 81

DAIC

APRIL 6, 2024

This hierarchical composite approach for assessing efficacy allows diverse types of outcomes to be incorporated in ranked fashion into an overall “win ratio” reflecting the overall outcome of a drug or device.

Heart Failure 75

Heart Failure Quality of Life Preserved Ejection Fraction Hospital 75

Cardiometabolic Health Congress

MARCH 8, 2024

Anuradha Lala-Trindade, MD: She focuses on the selection and care of patients with mechanical circulatory support devices and heart transplantation, genetic cardiomyopathies, and perioperative management of high-risk cardiac surgical cases.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59

Dr. Sanjay Gupta

MARCH 6, 2022

Other interventions that can help are devices known as left ventricular assist devices which can mechanically augment the pumping function of the heart and in the most severe cases, there is even the option of heart transplantation which whilst a huge undertaking can completely change a person’s life.

Chronic Disease 40

Chronic Disease Quality of Life Heart Failure Nursing 40

Dr. Smith's ECG Blog

JANUARY 9, 2023

No family history of sudden cardiac death, cardiomyopathy, premature CAD, or other cardiac issues. Pattern consistent with Takotsubo's cardiomyopathy." He was readmitted a few weeks later for a heart failure exacerbation, diuresed, and discharged again. She died before she could get a heart transplant.

Chest Pain 52

Chest Pain Aneurysm STEMI Thrombosis 52

Cardiology Update

APRIL 9, 2024

Patients receiving semaglutide showed a greater change in Kansas City Cardiomyopathy Questionnaire (KCCQ) clinical summary scores at 52 weeks than placebo. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes.

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52